Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E genotype regulates amyloid-beta cytotoxicity.

Micha M M Wilhelmus1, Irene Otte-Höller, Judianne Davis

  • 1Department of Neurology, Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands. m.wilhelmus@pathol.umcn.nl

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|April 9, 2005
PubMed
Summary

Apolipoprotein E (ApoE) genotype influences Alzheimer's disease (AD) risk by affecting amyloid-beta (Abeta) toxicity in brain cells. ApoE epsilon2 may protect against Abeta, while epsilon4 increases vulnerability, potentially due to varying ApoE secretion levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Serum aromatic l-amino acid decarboxylase activity as a biomarker for prodromal and manifest Parkinson's disease.

EBioMedicine·2026
Same author

Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical Variables.

Neurology·2026
Same author

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

The Lancet. Haematology·2026
Same author

Distinctive characteristics of dopamine neuron release mechanisms: Insights into Parkinson's Disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Spark or Sound: How Two Differing Explanatory Strategies Impact the Debate on the Physical Nature of Neuronal Excitability.

Membranes·2026

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • The apolipoprotein E (ApoE) epsilon4 allele is a known risk factor for Alzheimer's disease (AD), while the epsilon2 allele may offer protection.
  • Cerebral amyloid angiopathy (CAA) is linked to degeneration of cerebrovascular cells like smooth muscle cells and pericytes.
  • Amyloid-beta (Abeta) peptides, particularly Abeta1-40, can induce cell death in cerebrovascular cells, a process potentially influenced by ApoE.

Purpose of the Study:

  • To investigate the impact of apolipoprotein E (ApoE) genotype on the toxicity of amyloid-beta (Abeta) towards cerebrovascular cells.
  • To determine if variations in ApoE alleles (epsilon2, epsilon3, epsilon4) affect cellular vulnerability to Abeta-induced cell death.
  • To explore the role of ApoE secretion levels in modulating Abeta cytotoxicity based on ApoE genotype.

Related Experiment Videos

Main Methods:

  • Cultured cerebrovascular cells from different apolipoprotein E (ApoE) genotypes (epsilon4/epsilon4, epsilon3/epsilon3, epsilon3/epsilon4, epsilon2/epsilon3) were exposed to amyloid-beta (Abeta) peptides.
  • Cellular vulnerability to Abeta-mediated toxicity was assessed across the various ApoE genotypes.
  • Apolipoprotein E (ApoE) secretion levels were measured in cell cultures with different ApoE genotypes.

Main Results:

  • Cerebrovascular cells with the apolipoprotein E (ApoE) epsilon4/epsilon4 genotype exhibited greater vulnerability to amyloid-beta (Abeta) toxicity compared to epsilon3/epsilon3 or epsilon3/epsilon4 genotypes.
  • Cells with the ApoE epsilon2/epsilon3 genotype demonstrated relative resistance to Abeta-induced toxicity.
  • A dose-dependent protective effect of native ApoE against Abeta toxicity was observed, and ApoE epsilon2/epsilon3 cells secreted higher levels of ApoE compared to other genotypes, especially epsilon4/epsilon4.

Conclusions:

  • The apolipoprotein E (ApoE) genotype significantly influences the susceptibility of cerebrovascular cells to amyloid-beta (Abeta) toxicity.
  • Differences in cellular capacity to secrete ApoE, varying by genotype, may underlie the observed disparities in Abeta-mediated cytotoxicity.
  • Extracellular ApoE, modulated by genotype-dependent secretion, likely plays a protective role by binding to Abeta and mitigating its toxic effects on cerebrovascular cells, potentially impacting Alzheimer's disease risk.